Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating PEGASYS (peginterferon alfa-2a) in combination with adefovir or entecavir for HBeAg-positive chronic hepatitis B; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Hepsera (adefovir dipivoxil)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2015-11-20